Actively Recruiting
Patient Blood Management in Patients Scheduled for Cardiac Surgery
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-02-26
464
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation. In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.
CONDITIONS
Official Title
Patient Blood Management in Patients Scheduled for Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All adult patients scheduled for elective cardiac surgery
You will not qualify if you...
- Pregnancy
- Dialysis
- Patient's refusal
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Gemelli IRCCS
Roma, Italy, 00100
Actively Recruiting
Research Team
F
filippo Corsi, MD
CONTACT
L
Luciana Teofili, PhD, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here